Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients?

Saved in:
Bibliographic Details
Title: Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients?
Source: Internal Medicine Alert. 9/30/2021, Vol. 43 Issue 18, p1-2. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first